Art
J-GLOBAL ID:201902285641612728   Reference number:19A1863211

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

再発進行性尿路上皮癌におけるペムブロリズマブ対パクリタキセル,ドセタキセルまたはビンフルニンの第III相無作為化試験KEYNOTE-045: 2年以上の追跡結果
Author (21):
Material:
Volume: 30  Issue:Page: 970-976  Publication year: Jun. 2019 
JST Material Number: W0107A  ISSN: 0923-7534  CODEN: ANONE2  Document type: Article
Article type: 原著論文  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1863211&from=J-GLOBAL&jstjournalNo=W0107A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Clinical application of antitumor(=antineoplastic)drugs  ,  Urogenital tumors(=neoplasms) 

Return to Previous Page